Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62
10 suppliers awarded•16 lots awarded•€2.33M awarded
Buyer: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland
Awarded value
€2.33M
Estimated value
€2.33M
Awarded at 100% of estimated value
Award date
May 31, 2026
Winners
10
Lots awarded
16
Award values
Notice total
€2.33M
Sum of lot awards
€2.31M
TED notice total and lot-level values do not exactly match.
Winners
Warszawa, POL
€836,065 This contract
22 award notices•38 awarded lots•€27.54M total
Warszawa, POL
€546,556 This contract
27 award notices•46 awarded lots•€59.16M total
Warszawa, POL
€268,922 This contract
9 award notices•20 awarded lots•€13.25M total
Warszawa, POL
€148,595 This contract
127 award notices•182 awarded lots•€41.31M total
Warszawa, POL
€111,078 This contract
10 award notices•10 awarded lots•€526,882 total
Toruń, POL
€104,229 This contract
2 award notices•2 awarded lots•€873,788 total
Płochocin, POL
€82,243 This contract
41 award notices•128 awarded lots•€13.36M total
Budapeszt, HUN
€41,931 This contract
92 award notices•122 awarded lots•€54.70M total
Warszawa, POL
€27,332 This contract
21 award notices•38 awarded lots•€13.34M total
Wrocław, POL
€3,726 This contract
123 award notices•299 awarded lots•€230.18M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0049 | AMGEN SP. Z O.O. | €675,059 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0051 | Roche Polska Sp. z o.o. | €518,452 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0050 | ABBVIE Sp. z o.o. | €268,922 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0053 | Takeda Pharma Sp. z o.o. | €148,595 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0062 | Not specified | €140,516 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0059 | Centrala Farmaceutyczna Cefarm SA | €111,078 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0047 | NEUCA SPÓŁKA AKCYJNA | €104,229 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0054 | AMGEN SP. Z O.O. | €82,243 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0055 | Tramco Sp z o. o. | €82,243 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0058 | AMGEN SP. Z O.O. | €54,266 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0052 | Astrazeneca Kft. | €38,097 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0060 | Roche Polska Sp. z o.o. | €28,104 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0046 | Sanofi Sp. z o.o. | €27,332 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0061 | AMGEN SP. Z O.O. | €24,497 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0048 | Astrazeneca Kft. | €3,834 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0056 | Urtica Sp. z o.o. | €3,726 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) |